Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat model

Xiaohua Hong, Li Liu, Meiyun Wang, Kai Ding, Ying Fan, Bo Ma, Bachchu Lal, Betty Mae Tyler, Antonella Mangraviti, Silun Wang, John Wong, John J Laterra, Jinyuan Zhou

Research output: Contribution to journalArticle

Abstract

Background The inability of structural MRI to accurately measure tumor response to therapy complicates care management for patients with gliomas. The purpose of this study was to assess the potential of several noninvasive functional and molecular MRI biomarkers for the assessment of glioma response to radiotherapy. Methods Fourteen U87 tumor-bearing rats were irradiated using a small-animal radiation research platform (40 or 20 Gy), and 6 rats were used as controls. MRI was performed on a 4.7 T animal scanner, preradiation treatment, as well as at 3, 6, 9, and 14 days postradiation. Image features of the tumors, as well as tumor volumes and animal survival, were quantitatively compared. Results Structural MRI showed that all irradiated tumors still grew in size during the initial days postradiation. The apparent diffusion coefficient (ADC) values of tumors increased significantly postradiation (40 and 20 Gy), except at day 3 postradiation, compared with preradiation. The tumor blood flow decreased significantly postradiation (40 and 20 Gy), but the relative blood flow (tumor vs contralateral) did not show a significant change at most time points postradiation. The amide proton transfer weighted (APTw) signals of the tumor decreased significantly at all time points postradiation (40 Gy), and also at day 9 postradiation (20 Gy). The blood flow and APTw maps demonstrated tumor features that were similar to those seen on gadolinium-enhanced T 1-weighted images. Conclusions Tumor ADC, blood flow, and APTw were all useful imaging biomarkers by which to predict glioma response to radiotherapy. The APTw signal was most promising for early response assessment in this model.

Original languageEnglish (US)
Pages (from-to)856-867
Number of pages12
JournalNeuro-Oncology
Volume16
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Glioma
Radiotherapy
Neoplasms
Amides
Protons
Biomarkers
Patient Care Management
Gadolinium
Tumor Burden
Magnetic Resonance Imaging
Radiation
Therapeutics

Keywords

  • APT imaging
  • glioma
  • multiparametric MRI
  • radiotherapy
  • response assessment

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Clinical Neurology
  • Medicine(all)

Cite this

Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat model. / Hong, Xiaohua; Liu, Li; Wang, Meiyun; Ding, Kai; Fan, Ying; Ma, Bo; Lal, Bachchu; Tyler, Betty Mae; Mangraviti, Antonella; Wang, Silun; Wong, John; Laterra, John J; Zhou, Jinyuan.

In: Neuro-Oncology, Vol. 16, No. 6, 2014, p. 856-867.

Research output: Contribution to journalArticle

Hong, Xiaohua ; Liu, Li ; Wang, Meiyun ; Ding, Kai ; Fan, Ying ; Ma, Bo ; Lal, Bachchu ; Tyler, Betty Mae ; Mangraviti, Antonella ; Wang, Silun ; Wong, John ; Laterra, John J ; Zhou, Jinyuan. / Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat model. In: Neuro-Oncology. 2014 ; Vol. 16, No. 6. pp. 856-867.
@article{1a6fc90014fd47679959d20a60ea345a,
title = "Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat model",
abstract = "Background The inability of structural MRI to accurately measure tumor response to therapy complicates care management for patients with gliomas. The purpose of this study was to assess the potential of several noninvasive functional and molecular MRI biomarkers for the assessment of glioma response to radiotherapy. Methods Fourteen U87 tumor-bearing rats were irradiated using a small-animal radiation research platform (40 or 20 Gy), and 6 rats were used as controls. MRI was performed on a 4.7 T animal scanner, preradiation treatment, as well as at 3, 6, 9, and 14 days postradiation. Image features of the tumors, as well as tumor volumes and animal survival, were quantitatively compared. Results Structural MRI showed that all irradiated tumors still grew in size during the initial days postradiation. The apparent diffusion coefficient (ADC) values of tumors increased significantly postradiation (40 and 20 Gy), except at day 3 postradiation, compared with preradiation. The tumor blood flow decreased significantly postradiation (40 and 20 Gy), but the relative blood flow (tumor vs contralateral) did not show a significant change at most time points postradiation. The amide proton transfer weighted (APTw) signals of the tumor decreased significantly at all time points postradiation (40 Gy), and also at day 9 postradiation (20 Gy). The blood flow and APTw maps demonstrated tumor features that were similar to those seen on gadolinium-enhanced T 1-weighted images. Conclusions Tumor ADC, blood flow, and APTw were all useful imaging biomarkers by which to predict glioma response to radiotherapy. The APTw signal was most promising for early response assessment in this model.",
keywords = "APT imaging, glioma, multiparametric MRI, radiotherapy, response assessment",
author = "Xiaohua Hong and Li Liu and Meiyun Wang and Kai Ding and Ying Fan and Bo Ma and Bachchu Lal and Tyler, {Betty Mae} and Antonella Mangraviti and Silun Wang and John Wong and Laterra, {John J} and Jinyuan Zhou",
year = "2014",
doi = "10.1093/neuonc/not245",
language = "English (US)",
volume = "16",
pages = "856--867",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat model

AU - Hong, Xiaohua

AU - Liu, Li

AU - Wang, Meiyun

AU - Ding, Kai

AU - Fan, Ying

AU - Ma, Bo

AU - Lal, Bachchu

AU - Tyler, Betty Mae

AU - Mangraviti, Antonella

AU - Wang, Silun

AU - Wong, John

AU - Laterra, John J

AU - Zhou, Jinyuan

PY - 2014

Y1 - 2014

N2 - Background The inability of structural MRI to accurately measure tumor response to therapy complicates care management for patients with gliomas. The purpose of this study was to assess the potential of several noninvasive functional and molecular MRI biomarkers for the assessment of glioma response to radiotherapy. Methods Fourteen U87 tumor-bearing rats were irradiated using a small-animal radiation research platform (40 or 20 Gy), and 6 rats were used as controls. MRI was performed on a 4.7 T animal scanner, preradiation treatment, as well as at 3, 6, 9, and 14 days postradiation. Image features of the tumors, as well as tumor volumes and animal survival, were quantitatively compared. Results Structural MRI showed that all irradiated tumors still grew in size during the initial days postradiation. The apparent diffusion coefficient (ADC) values of tumors increased significantly postradiation (40 and 20 Gy), except at day 3 postradiation, compared with preradiation. The tumor blood flow decreased significantly postradiation (40 and 20 Gy), but the relative blood flow (tumor vs contralateral) did not show a significant change at most time points postradiation. The amide proton transfer weighted (APTw) signals of the tumor decreased significantly at all time points postradiation (40 Gy), and also at day 9 postradiation (20 Gy). The blood flow and APTw maps demonstrated tumor features that were similar to those seen on gadolinium-enhanced T 1-weighted images. Conclusions Tumor ADC, blood flow, and APTw were all useful imaging biomarkers by which to predict glioma response to radiotherapy. The APTw signal was most promising for early response assessment in this model.

AB - Background The inability of structural MRI to accurately measure tumor response to therapy complicates care management for patients with gliomas. The purpose of this study was to assess the potential of several noninvasive functional and molecular MRI biomarkers for the assessment of glioma response to radiotherapy. Methods Fourteen U87 tumor-bearing rats were irradiated using a small-animal radiation research platform (40 or 20 Gy), and 6 rats were used as controls. MRI was performed on a 4.7 T animal scanner, preradiation treatment, as well as at 3, 6, 9, and 14 days postradiation. Image features of the tumors, as well as tumor volumes and animal survival, were quantitatively compared. Results Structural MRI showed that all irradiated tumors still grew in size during the initial days postradiation. The apparent diffusion coefficient (ADC) values of tumors increased significantly postradiation (40 and 20 Gy), except at day 3 postradiation, compared with preradiation. The tumor blood flow decreased significantly postradiation (40 and 20 Gy), but the relative blood flow (tumor vs contralateral) did not show a significant change at most time points postradiation. The amide proton transfer weighted (APTw) signals of the tumor decreased significantly at all time points postradiation (40 Gy), and also at day 9 postradiation (20 Gy). The blood flow and APTw maps demonstrated tumor features that were similar to those seen on gadolinium-enhanced T 1-weighted images. Conclusions Tumor ADC, blood flow, and APTw were all useful imaging biomarkers by which to predict glioma response to radiotherapy. The APTw signal was most promising for early response assessment in this model.

KW - APT imaging

KW - glioma

KW - multiparametric MRI

KW - radiotherapy

KW - response assessment

UR - http://www.scopus.com/inward/record.url?scp=84901054157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901054157&partnerID=8YFLogxK

U2 - 10.1093/neuonc/not245

DO - 10.1093/neuonc/not245

M3 - Article

C2 - 24366911

AN - SCOPUS:84901054157

VL - 16

SP - 856

EP - 867

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 6

ER -